These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22547315)

  • 1. The biological effects of ivabradine in cardiovascular disease.
    Speranza L; Franceschelli S; Riccioni G
    Molecules; 2012 Apr; 17(5):4924-35. PubMed ID: 22547315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D; Borer JS
    Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
    Bucchi A; Tognati A; Milanesi R; Baruscotti M; DiFrancesco D
    J Physiol; 2006 Apr; 572(Pt 2):335-46. PubMed ID: 16484306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.
    Koncz I; Szél T; Jaeger K; Baczkó I; Cerbai E; Romanelli MN; Gy Papp J; Varró A
    Curr Med Chem; 2011; 18(24):3662-74. PubMed ID: 21774761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
    J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I(f) inhibition in cardiovascular diseases.
    Thollon C; Vilaine JP
    Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping.
    Heusser K; Tank J; Brinkmann J; Schroeder C; May M; Großhennig A; Wenzel D; Diedrich A; Sweep FC; Mehling H; Luft FC; Jordan J
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26764413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular Disease.
    Nawarskas JJ; Bowman BN; Anderson JR
    Cardiol Rev; 2015; 23(4):201-11. PubMed ID: 25839989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S; Ebelt H; Hoke RS; Krummenerl A; Wienke A; Müller-Werdan U; Werdan K
    Clin Res Cardiol; 2011 Oct; 100(10):915-23. PubMed ID: 21638157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.
    Petite SE; Bishop BM; Mauro VF
    Am J Ther; 2018; 25(2):e247-e266. PubMed ID: 26910057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R; Ceconi C
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL; Francis KE; Lowe DK; Cahoon WD
    Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):348-352. PubMed ID: 27659287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine for the Treatment of Cardiovascular Diseases.
    Ide T; Ohtani K; Higo T; Tanaka M; Kawasaki Y; Tsutsui H
    Circ J; 2019 Jan; 83(2):252-260. PubMed ID: 30606942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U; Stöckl G; Werdan K
    Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine.
    Bucchi A; Baruscotti M; DiFrancesco D
    J Gen Physiol; 2002 Jul; 120(1):1-13. PubMed ID: 12084770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of ivabradine in chronic heart failure (review)].
    Isakadze A; Makharadze T; Gvishiani M
    Georgian Med News; 2015 Apr; (241):44-9. PubMed ID: 25953938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L; Simonsen U; Grimm D; Hedegaard ER
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I; Camm AJ
    Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of selective heart rate reduction through sinus node I
    Sisakian H; Sargsyan T; Khachatryan A
    Acta Cardiol; 2016 Jun; 71(3):317-22. PubMed ID: 27594127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.